6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent: Prospective, Randomized, Multicenter Trial

被引：1
|
作者：
Lee, Byoung Kwon [1 ]
Bum-Kee, Hong [1 ]
Yoon, Young Won [1 ]
Min, Pil-Ki [2 ]
Kwon, Hyuck Moon [2 ]
Kim, Byoung Keuk [3 ]
Hong, Myeong-Ki [3 ]
Jang, Yang Soo [3 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Div Cardiol, Cardiovasc Ctr, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 62卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2013.08.735
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B3 / B4
页数：2
相关论文
共 50 条
  • [41] Two-Year Clinical Results of Patients Randomized to 3-or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE
    Feres, Fausto
    Devito, Fernando S.
    Costa, Ricardo A.
    Abizaid, Alexandre
    Leon, Martin
    Botelho, Roberto
    King, Spencer, III
    Perin, Marco A.
    Staico, Rodolfo
    Costa, Jose D., Jr.
    Abizaid, Andrea
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B141 - B141
  • [42] Safety and Efficacy of 6-Month Versus 12-Month Dual Antiplatelet Therapy in Patients After Implantation of Multiple Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Insight From the I-LOVE-IT 2 Trial
    Qi, Jing
    Li, Yi
    Li, Jing
    Jing, Quanmin
    Xu, Kai
    Gao, Chuanyu
    Ma, Likun
    Zhang, Zhi
    Xu, Bo
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 : 555 - 564
  • [43] A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with diabetes who underwent drug eluting stent implantation (Cilostazol for diabetic patients in drug-eluting stent CIDES trial)
    Ann, Youngkeun
    Jeong, Myung Ho
    Jeong, Jong Weon
    Ahn, Tae Hoon
    Park, Chang-Gyu
    Kim, Jong Hyun
    Chae, In-Ho
    Hur, Seung Ho
    Bae, Jang Ho
    Oh, Seok Kyu
    CIRCULATION, 2006, 114 (18) : 588 - 589
  • [44] Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
    Gérard Helft
    Claude Le Feuvre
    Jean Louis Georges
    Didier Carrie
    Florence Leclercq
    Hélène Eltchaninoff
    Alain Furber
    Fabrice Prunier
    Laurent Sebagh
    Simon Cattan
    Guillaume Cayla
    Eric Vicaut
    Jean-Philippe Metzger
    Trials, 14
  • [45] Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
    Helft, Gerard
    Le Feuvre, Claude
    Georges, Jean Louis
    Carrie, Didier
    Leclercq, Florence
    Eltchaninoff, Helene
    Furber, Alain
    Prunier, Fabrice
    Sebagh, Laurent
    Cattan, Simon
    Cayla, Guillaume
    Vicaut, Eric
    Metzger, Jean-Philippe
    TRIALS, 2013, 14
  • [46] A New Strategy for Discontinuation of Dual Antiplatelet Therapy The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
    Kim, Byeong-Keuk
    Hong, Myeong-Ki
    Shin, Dong-Ho
    Nam, Chung-Mo
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Kang, Tae-Soo
    Park, Byoung-Eun
    Kang, Woong-Chol
    Lee, Seung-Hwan
    Yoon, Jung-Han
    Hong, Bum-Kee
    Kwon, Hyuck-Moon
    Jang, Yangsoo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1340 - 1348
  • [47] Prospective multicenter registry of 6 months dual antiplatelet therapy after new generation drug-eluting stent implantation: ESTROFA-DAPT study
    De La Torre Hernandez, J. M.
    Oteo, J. F.
    Hernandez, F.
    Altisent, O. Abdul-Jawad
    Rivero, F.
    Cascon, J. D.
    Zavala, G.
    Gimeno, F.
    Arrebola, A. L.
    Gomez Menchero, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 976 - 977
  • [48] Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study
    De la Torre Hernandez, Jose M.
    Oteo Dominguez, Juan F.
    Hernandez, Felipe
    Abdul-Jawad Altisent, Omar
    Rivero-Crespo, Fernando
    Cascon, Jose D.
    Arrebola, Antonio L.
    Gimeno, Federico
    Zavala, German
    Andraka, Leire
    Gomez Menchero, Antonio
    Bosa, Francisco
    Carrillo, Xavier
    De Lemos, Rocio
    Moreno, Antonio Ramirez
    Castillo, Jose L.
    Sanchez-Recalde, Angel
    Tizon-Marcos, Helena
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B45 - B45
  • [49] Short Versus Long Duration of Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stents Implantation in Patients with Diabetes
    Gangwani, Manesh Kumar
    Aziz, Muhammad
    Chacko, Paul
    Mahmood, Asif
    Ali, Muhammad
    Priyanka, Fnu
    Munir, Siraj
    Aziz, Abeer
    Sagheer, Shazib
    Lee-Smith, Wade
    Parkash, Om
    Rai, Devesh
    Baibhav, Bipul
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (05) : E416 - E425
  • [50] Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study
    Valgimigli, Marco
    Patialiakas, Athanasios
    Thury, Attila
    Colangelo, Salvatore
    Campo, Gianluca
    Tebaldi, Matteo
    Ungi, Imre
    Tondi, Stefano
    Roffi, Marco
    Menozzi, Alberto
    de Cesare, Nicoletta
    Garbo, Roberto
    Meliga, Emanuele
    Testa, Luca
    Gabriel, Henrique M.
    Airoldi, Flavio
    Ferlini, Marco
    Liistro, Francesco
    Dellavalle, Antonio
    Vranckx, Pascal
    Briguori, Carlo
    AMERICAN HEART JOURNAL, 2013, 166 (05) : 831 - 838
12345